Study of How Advanced Esophageal Cancer Spreads After Surgery
Part of Cancer, Digestive system clinical trials.
This research examines tissue samples from patients who had surgery to remove advanced esophageal cancer in the neck or chest area. The study aims to understand how the cancer invaded surrounding tissues, which may help doctors better treat similar patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had esophageal cancer (squamous cell type) in your neck or upper chest
- Your cancer was stage T2 or T3 (medium to advanced size) before surgery
- You underwent a specific type of surgical removal called McKeown esophagectomy
- You had only one main tumor (not multiple separate cancers)
- You have complete medical records and tissue samples available from your surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment plan that combines immunotherapy with chemotherapy before possible endoscopic surgery. It is for people with a specific type of esophageal cancer that has not been treated before and is either potentially removable or not suitable for standard surgery.
This study tracks changes in your tumor over time using advanced tests on blood and tissue samples. The goal is to better understand your cancer and help guide treatment for you and future patients.
This study tests whether giving additional immunotherapy after esophageal cancer surgery can help prevent the cancer from coming back. If you've already had chemotherapy and immunotherapy before surgery, this trial may offer a way to continue that benefit after your operation.
This study looks back at patients who received immunotherapy and chemotherapy before surgery for esophageal cancer, to see how often the cancer comes back after surgery. It may help doctors understand which patients benefit the most from this treatment approach.
This study compares two standard approaches for treating esophageal cancer before surgery: chemotherapy combined with radiation versus chemotherapy combined with immunotherapy. The goal is to see which approach works better for shrinking tumors and improving outcomes in patients whose cancer is considered removable.
This trial looks at how well the tumor responded to chemotherapy or radiation before surgery, to see if that can help doctors decide next steps like additional treatment. It may help people with esophageal squamous cell cancer who had the tumor removed completely after initial therapy.
Hear when a new Infiltration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.